Top Clinical Trials companies in Netherlands by Cash and Short-Term Investments
Netherlands
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 3.18 B
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
| 2 |
USD 617.89 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
| 3 |
USD 431.82 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
| 4 |
USD 355.18 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 5 |
USD 340.45 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 6 |
USD 131.26 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
| 7 |
USD 95.57 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
Frequently Asked Questions
-
Which Clinical Trials company in Netherlands has the highest Cash and Short-Term Investments ?
The Clinical Trials company in Netherlands with the highest Cash and Short-Term Investments is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 3.18 B.
-
Which Clinical Trials company in Netherlands has the lowest Cash and Short-Term Investments ?
The Clinical Trials company in Netherlands with the lowest Cash and Short-Term Investments is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 95.57 M.
-
What are the top 10 Clinical Trials companies in Netherlands by Cash and Short-Term Investments ?
The top 10 Clinical Trials companies in Netherlands by Cash and Short-Term Investments are argenx SE, uniQure N.V., Pharvaris N.V., Merus N.V., NewAmsterdam Pharma Company N.V., ProQR Therapeutics N.V. and LAVA Therapeutics N.V..
-
What are the bottom 10 Clinical Trials companies in Netherlands by Cash and Short-Term Investments ?
The bottom 10 Clinical Trials companies in Netherlands by Cash and Short-Term Investments are LAVA Therapeutics N.V., ProQR Therapeutics N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V., uniQure N.V. and argenx SE.
